SomaLogic, Inc., a pioneering leader in proteomics, is headquartered in the United States and operates across key regions globally. Founded in 2000, the company has made significant strides in the biotechnology industry, focusing on advanced protein analysis to enhance healthcare outcomes. SomaLogic's flagship product, the SomaScan® platform, uniquely enables the measurement of thousands of proteins simultaneously, providing invaluable insights for research and clinical applications. This innovative technology positions SomaLogic at the forefront of precision medicine, allowing for more personalised treatment strategies. With a strong market presence and notable achievements in biomarker discovery, SomaLogic continues to drive advancements in health diagnostics, making it a vital player in the evolving landscape of biotechnology.
We don't have data for SomaLogic, Inc., but we can show you information about their parent organization instead.
View parent company